<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Viruses</journal-id><journal-id journal-id-type="iso-abbrev">Viruses</journal-id><journal-id journal-id-type="publisher-id">viruses</journal-id><journal-title-group><journal-title>Viruses</journal-title></journal-title-group><issn pub-type="epub">1999-4915</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11680219</article-id><article-id pub-id-type="doi">10.3390/v16121909</article-id><article-id pub-id-type="publisher-id">viruses-16-01909</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Saliva Diagnostics in Spaceflight Virology Studies&#x02014;A Review</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Diak</surname><given-names>Douglass M.</given-names></name><xref rid="af1-viruses-16-01909" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Crucian</surname><given-names>Brian E.</given-names></name><xref rid="af2-viruses-16-01909" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Nelman-Gonzalez</surname><given-names>Mayra</given-names></name><xref rid="af3-viruses-16-01909" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4198-3261</contrib-id><name><surname>Mehta</surname><given-names>Satish K.</given-names></name><xref rid="af4-viruses-16-01909" ref-type="aff">4</xref><xref rid="c1-viruses-16-01909" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Garbuglia</surname><given-names>Anna Rosa</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Bordi</surname><given-names>Licia</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-viruses-16-01909"><label>1</label>Aegis Aerospace, Human Health and Performance Directorate, Houston, TX 77058, USA; <email>douglass.m.diak@nasa.gov</email></aff><aff id="af2-viruses-16-01909"><label>2</label>National Aeronautics and Space Administration (NASA) Johnson Space Center, Human Health and Performance Directorate, Houston, TX 77058, USA</aff><aff id="af3-viruses-16-01909"><label>3</label>KBR, Human Health and Performance Directorate, Houston, TX 77058, USA; <email>mayra.a.nelman@nasa.gov</email></aff><aff id="af4-viruses-16-01909"><label>4</label>JES Tech, Human Health and Performance Directorate, Houston, TX 77058, USA</aff><author-notes><corresp id="c1-viruses-16-01909"><label>*</label>Correspondence: <email>satish.k.mehta@nasa.gov</email></corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2024</year></pub-date><volume>16</volume><issue>12</issue><elocation-id>1909</elocation-id><history><date date-type="received"><day>11</day><month>11</month><year>2024</year></date><date date-type="rev-recd"><day>02</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>06</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; 2024 by the authors.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Many biological markers of normal and disease states can be detected in saliva. The benefits of saliva collection for research include being non-invasive, ease of frequent sample collection, saving time, and being cost-effective. A small volume (&#x02248;1 mL) of saliva is enough for these analyses that can be collected in just a few minutes. For &#x0201c;dry&#x0201d; saliva paper matrices, additional drying times (about 30 min) may be needed, but this can be performed at room temperature without the need for freezers and specialized equipment. Together, these make saliva an ideal choice of body fluid for many clinical studies from diagnosis to monitoring measurable biological substances in hospital settings, remote, and other general locations including disaster areas. For these reasons, we have been using saliva (dry as well as wet) from astronauts participating in short- and long-duration space missions for over two decades to conduct viral, stress, and immunological studies. We have also extended the use of saliva to space analogs including bed rest, Antarctica, and closed-chamber studies. Saliva is a biomarker-rich and easily accessible body fluid that could enable larger and faster public health screenings, earlier disease detection, and improved patient outcomes. This review summarizes our lessons learned from utilizing saliva in spaceflight research and highlights the advantages and disadvantages of saliva in clinical diagnostics.</p></abstract><kwd-group><kwd>saliva</kwd><kwd>spaceflight</kwd><kwd>herpesviruses</kwd><kwd>International Space Station</kwd><kwd>biomarkers</kwd><kwd>immune</kwd></kwd-group><funding-group><award-group><funding-source>NASA&#x02019;s Human Research Program</funding-source></award-group><funding-statement>The studies were supported by NASA&#x02019;s Human Research Program via NASA-funded grants.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-viruses-16-01909"><title>1. Introduction</title><p>Saliva has been used for the detection of biological markers for a wide spectrum of normal and disease states in humans for a long time. It is a non-invasive, easily accessible, and self-collected body fluid that contains a variety of measurable biological substances. While mostly water, saliva also contains ions, carbohydrates, proteins and peptides, exfoliated cells, nucleic acids, and microorganisms [<xref rid="B1-viruses-16-01909" ref-type="bibr">1</xref>]. This complex set of ingredients plays a critical role in maintaining oral health. However, it can also serve as a window into systemic health when circulating blood analytes transport across the blood&#x02013;saliva barrier (BSB) and mix with normal excretions of saliva produced by the saliva glands. Indeed, the concentration of many biological markers may be low or variable because permeation of the BSB occurs largely by passive, paracellular diffusion [<xref rid="B2-viruses-16-01909" ref-type="bibr">2</xref>], although active transport across epithelial membranes has also been described [<xref rid="B3-viruses-16-01909" ref-type="bibr">3</xref>]. Additional variations in biomarker analysis may arise if the salivary flow rate or diurnal variations are not accounted for. In any case, with proper sampling controls, these salivary analytes can provide insights into systemic emotional, hormonal, immunological, neurological, microbiological, nutritional, and metabolic states [<xref rid="B4-viruses-16-01909" ref-type="bibr">4</xref>]. Even therapeutic and non-therapeutic drugs including psychotropic drugs, chemotherapeutic agents [<xref rid="B5-viruses-16-01909" ref-type="bibr">5</xref>], and illicit substances like marijuana, cocaine, and alcohol [<xref rid="B4-viruses-16-01909" ref-type="bibr">4</xref>,<xref rid="B6-viruses-16-01909" ref-type="bibr">6</xref>] may be monitored in saliva. Furthermore, a variety of candidate salivary biomarkers are being discovered to assist in screening and diagnosing oral diseases like gingivitis [<xref rid="B7-viruses-16-01909" ref-type="bibr">7</xref>] or oral squamous cell carcinoma [<xref rid="B8-viruses-16-01909" ref-type="bibr">8</xref>]. As such, saliva is a multifaceted body fluid that not only provides information about local health but may also mirror that of systemic profiles.</p><p>Even with all these significant advantages, saliva has been generally underutilized in clinical research and diagnostics. However, due to the COVID-19 pandemic and large-scale viral testing, saliva collections have become common practice globally. Initially, population screenings were largely gathered by nasopharyngeal swabs, but these were uncomfortable and difficult to perform, especially for less than cooperative subjects, like children. Not surprisingly, suboptimal swab collections were a major contributor to false-negative COVID-19 test results [<xref rid="B9-viruses-16-01909" ref-type="bibr">9</xref>]. Fortunately, research has shown that saliva-based diagnostics, which are easier to collect, have comparable sensitivity and specificity to nasopharyngeal swabs for viral testing [<xref rid="B10-viruses-16-01909" ref-type="bibr">10</xref>]. While nasopharyngeal swabs may still be the gold standard, saliva testing has been widely adopted for COVID-19 testing [<xref rid="B11-viruses-16-01909" ref-type="bibr">11</xref>]. As such, the medical community only recently realized the significance of using saliva as an easier means of screening for viral positivity (i.e., SARS-CoV-2) in the population. However, saliva has been used for decades supporting virology investigations at NASA to screen for viruses and, particularly, the reactivation of latent herpesviruses [<xref rid="B12-viruses-16-01909" ref-type="bibr">12</xref>,<xref rid="B13-viruses-16-01909" ref-type="bibr">13</xref>,<xref rid="B14-viruses-16-01909" ref-type="bibr">14</xref>,<xref rid="B15-viruses-16-01909" ref-type="bibr">15</xref>,<xref rid="B16-viruses-16-01909" ref-type="bibr">16</xref>,<xref rid="B17-viruses-16-01909" ref-type="bibr">17</xref>,<xref rid="B18-viruses-16-01909" ref-type="bibr">18</xref>,<xref rid="B19-viruses-16-01909" ref-type="bibr">19</xref>,<xref rid="B20-viruses-16-01909" ref-type="bibr">20</xref>,<xref rid="B21-viruses-16-01909" ref-type="bibr">21</xref>]. Herein, this review will highlight the advantages and disadvantages of saliva in clinical diagnostics and summarize our lessons learned from utilizing saliva in spaceflight viral research.</p></sec><sec id="sec2-viruses-16-01909"><title>2. Advantage/Disadvantage of Saliva over Plasma or Serum</title><p>Saliva has many advantages over blood as a research and clinical diagnostic tool. Its collection, storage, and shipment (if necessary) are straightforward and economical. For patients, particularly those with trypanophobia, the non-invasive collecting technique significantly alleviates anxiety and discomfort [<xref rid="B22-viruses-16-01909" ref-type="bibr">22</xref>], likely providing a truer analytical value than one riddled with additional biological stress responses. Unlike phlebotomy, which requires specialized equipment, storage reagents, and trained personnel, saliva collection can be performed by the patient via a simple passive-drooling procedure (unstimulated), chewing a paraffin pellet (stimulated), or saturation of a synthetic swab held in the cheek area for a few minutes. Although unique passive-drool and saliva swab storage containers have been developed to simplify downstream processes, no specific equipment is essential, and saliva can be collected and frozen in a simple tube (i.e., 1&#x02013;50 mL conical tube). In contrast to blood collections, when repeated sampling is required, an indwelling catheter may be placed or repeated venipunctures occur with a needle. Both of these procedures increase the risk of secondary infections, which is not only harmful for the patient but also to the results for the analyte of interest. Saliva collections simplify this process, allowing for the gathering of repeated samples for longitudinal monitoring over time.</p><p>While usually not a perfect match, numerous studies have shown correlations between serum/plasma and saliva levels. In addition to cross-sectional sampling, both diurnal and monthly profiles of salivary hormone levels are comparable to systemic serum patterns [<xref rid="B23-viruses-16-01909" ref-type="bibr">23</xref>] and can be used to monitor fertility cycles, menopausal fluctuations, and stress [<xref rid="B24-viruses-16-01909" ref-type="bibr">24</xref>]. Recent research has revealed that immunoglobulins, particularly IgG but also IgA and IgM, are significantly correlated between saliva and blood [<xref rid="B25-viruses-16-01909" ref-type="bibr">25</xref>,<xref rid="B26-viruses-16-01909" ref-type="bibr">26</xref>]. With recent technological advances in proteomics, over 2000&#x02013;3000 salivary proteins and peptides [<xref rid="B27-viruses-16-01909" ref-type="bibr">27</xref>,<xref rid="B28-viruses-16-01909" ref-type="bibr">28</xref>] have been discovered to mirror that of their circulating counterparts. However, while this roughly 30% overlap is respectable, analytes in saliva are generally present in lower amounts or absent completely compared to blood [<xref rid="B4-viruses-16-01909" ref-type="bibr">4</xref>]. Thus, it is important for the researcher or clinician to know the limit of detection in saliva for the analyte of interest. Conversely, having too much of an analyte via blood contamination or local oral inflammation can produce inaccurate results with false positives or extremely high levels. Patients with oral pathologies, like gingivitis or periodontitis, are generally excluded from saliva research, with the exception of diagnosing that specific encumbrance. Furthermore, while saliva does not clot like blood samples, inadequate hydration, smoking, or excess mucus from allergies can make it quite thick and viscous, proving technically difficult to manipulate in the lab.</p><p>Blood collection tubes (BCTs) also already contain a preservative to maintain sample integrity for a period of time. Depending upon the analyte of interest, BCTs can also be refrigerated or frozen to help reduce the breakdown of the sample. For raw saliva, it is essential to freeze the sample as quickly as possible to maintain sample integrity (usually protein analysis). Refrigeration for up to 2 h is also nominal, when immediate freezing is not an option. This helps minimize degradation of the sample by enzymatic activity via amylases, proteases, and lysozymes while also reducing microbial growth and contamination [<xref rid="B29-viruses-16-01909" ref-type="bibr">29</xref>]. Thus, it is important to mitigate the effects of these enzymes and preserve the integrity of the samples for scientific analysis. Some have tested protocols utilizing protease inhibitor cocktails to protect from saliva protein degradation, but the results from these tests are mixed [<xref rid="B30-viruses-16-01909" ref-type="bibr">30</xref>,<xref rid="B31-viruses-16-01909" ref-type="bibr">31</xref>]. Others have developed DNA preservation buffers that when added to the saliva sample may preserve DNA integrity for up to 24 months when stored at room temperature [<xref rid="B32-viruses-16-01909" ref-type="bibr">32</xref>]. In our studies, we found that simply freezing the sample immediately (&#x02212;20 &#x000b0;C or lower) and then limiting downstream freeze/thaw cycles by initial sample aliquoting produces the best results.</p></sec><sec id="sec3-viruses-16-01909"><title>3. Saliva for Viral Studies</title><p>Saliva has been reliably used to detect HIV 1 and 2, viral hepatitis A, B, and C [<xref rid="B4-viruses-16-01909" ref-type="bibr">4</xref>], and many human herpes viruses including EBV, CMV, HSV 1 and 2, VZV, and HHV6. Some of these herpesviruses (alpha herpes viruses, like VZV and HSV1) are neurotropic (reside in the nervous system), but recent studies have shown that they can be found in saliva as well [<xref rid="B33-viruses-16-01909" ref-type="bibr">33</xref>]. During our spaceflight studies at Johnson Space Center, NASA, we used saliva to detect herpes virus DNA by real-time quantitative PCR. These studies were carried out in ground-based space analogs including Antarctica [<xref rid="B34-viruses-16-01909" ref-type="bibr">34</xref>], bed rest studies, NASA&#x02019;s underwater studies (NEEMO), and artificial gravity models, as well as in short- and long-duration space missions [<xref rid="B21-viruses-16-01909" ref-type="bibr">21</xref>]. Epstein&#x02013;Barr virus (EBV), a gamma herpes virus, one of the most common latent herpes viruses, reactivated and shed in larger quantities coincidentally with decreasing immunity [<xref rid="B35-viruses-16-01909" ref-type="bibr">35</xref>,<xref rid="B36-viruses-16-01909" ref-type="bibr">36</xref>] in the saliva of the subjects in these studies. These studies were also expanded to include other herpes viruses, like cytomegalovirus (CMV) [<xref rid="B37-viruses-16-01909" ref-type="bibr">37</xref>] and HSV1 [<xref rid="B38-viruses-16-01909" ref-type="bibr">38</xref>]. Unsurprisingly, these viruses also showed similar trends, in that spaceflight stress and immune dysregulation induced a reactivation of latent viral replication, including some cases of adverse clinical events where medical intervention was needed. In addition, we also studied varicella zoster virus (VZV), a neurotropic alpha herpesvirus. Its primary infection usually causes varicella (chicken pox), after which the virus becomes latent in ganglionic neurons along the entire neuroaxis [<xref rid="B39-viruses-16-01909" ref-type="bibr">39</xref>,<xref rid="B40-viruses-16-01909" ref-type="bibr">40</xref>]. Later in life, it can reactivate to produce zoster (shingles). In some cases, it can be followed by chronic pain (postherpetic neuralgia [PHN]), mostly in individuals 60 years of age or older. We reported that spaceflight-associated stress resulted in the reactivation and shedding of VZV in the saliva of otherwise healthy astronauts asymptomatically during and after the flight that later on was also shown to be a live and infectious virus [<xref rid="B14-viruses-16-01909" ref-type="bibr">14</xref>] which would have a potential risk of infecting seronegative individuals that were on board. These findings highlight the significant risk of latent herpes viral reactivations and shedding in astronauts during and after spaceflight and the need for directed immune countermeasures (see review for more information [<xref rid="B41-viruses-16-01909" ref-type="bibr">41</xref>]).</p><p>We are also utilizing and innovating with &#x0201c;dry saliva&#x0201d; technologies for herpes viral assessment. This technology is similar to what we developed for stress hormones (see the Saliva for Stress Hormones Section for more details). Dry saliva is uniquely suitable for deep space mission constraints (i.e., to the Moon and Mars) due to low volume, no processing requirement, and no conditioned storage (i.e., freezer). As opposed to raw saliva collections which entail a passive-drool of saliva in a volumetric container or saturating an oral swab and then freezing the sample, dry saliva collections utilize specialized filter paper materials that maintain sample integrity upon drying at room temperature. The storage of dried saliva matrices, which requires unconditioned stowage, is energy-, space-, and cost-effective, making this an excellent tool for collection when extreme sample-to-lab issues arise. This collection process is similar to that of &#x0201c;dry blood spots&#x0201d; which have been standardized and used extensively in many diagnostic applications, especially for newborns [<xref rid="B42-viruses-16-01909" ref-type="bibr">42</xref>]. The paper matrix is saturated either directly by mouth or, if the paper has a chemical preservative applied to it to enhance sample integration, by separate application by pipette from a pooled raw saliva sample. The paper is then dried at room temperature and stored in a unique stabilization bag with a desiccant until processing in the lab. Potential limitations to these methods arise from the need for specialized pretreatment or rehydration protocols of the dry paper matrices for less stable analytes. Current research in our lab is optimizing protocol requirements for about 80 different analytes for dry saliva diagnostics (unpublished to date). Filter paper type (i.e., with or without chemical additives) and quantities depend on downstream applications, but a variety of matrices have been created to ensure diagnostic analyte integrity, including those for viral DNA/RNA and protein analysis as well as chemistry biomarkers. The ultimate aim of this technology is to achieve results in our target analytes which are comparable to frozen samples.</p><p>Our spaceflight-developed technologies of saliva collection in remote locations, even without gravity, storing at room temperature, and processing for rapid viral detection, have been applied to diagnose various clinical conditions including acute zoster [<xref rid="B43-viruses-16-01909" ref-type="bibr">43</xref>], zoster sine herpete [<xref rid="B44-viruses-16-01909" ref-type="bibr">44</xref>], chickenpox [<xref rid="B45-viruses-16-01909" ref-type="bibr">45</xref>], and postherpetic neuralgia (PHN) [<xref rid="B46-viruses-16-01909" ref-type="bibr">46</xref>]. Viral detection has been demonstrated even before the rash appears, which now makes diagnosis less invasive and less time-consuming. In fact, a rapid and sensitive virus detection method has been developed and used to detect virus in saliva samples taken from asymptomatic patients with neurologic and other VZV-related disease [<xref rid="B45-viruses-16-01909" ref-type="bibr">45</xref>], multiple sclerosis [<xref rid="B47-viruses-16-01909" ref-type="bibr">47</xref>], and various other neurological disorders [<xref rid="B48-viruses-16-01909" ref-type="bibr">48</xref>,<xref rid="B49-viruses-16-01909" ref-type="bibr">49</xref>]. These protocols are being employed in various clinics and hospitals, including the CDC and Columbia University in New York, as well as in Switzerland and Israel.</p></sec><sec id="sec4-viruses-16-01909"><title>4. Saliva for Stress Hormones</title><p>Because of our unique research environment and the link between stress, immunity, and viral reactivation, we devised a collection tool for the collection of human saliva samples for stress hormone assessments. This tool can be used at any remote location, including space, and does not require any special conditions for storage. Saliva samples are collected on filter paper and dried at room temperature. We developed a packaging appliance for these filters that was compact and easy to use, specifically for NASA, called the Saliva Procurement and Integrated Testing (SPIT) booklets (<xref rid="viruses-16-01909-f001" ref-type="fig">Figure 1</xref>). These booklets are being used to collect and store saliva samples from International Space Station crewmembers before, during, and after the spaceflight.</p><p>Using this specialized SPIT booklet, astronauts could take multiple samples throughout the day (from waking to right before sleeping), dry the entire booklet at ambient temperature, store it in specialized bags, and return them to Earth for analysis. This is a novel method of the collection of saliva samples that is non-invasive, inexpensive, does not require trained medical personnel, and can be stored at room temperature for at least 6 months without compromising the quality of the sample&#x02019;s stress hormone assessment. Following sample extraction methods from these filters (published methods here [<xref rid="B23-viruses-16-01909" ref-type="bibr">23</xref>]), steroid hormones can then be measured using any commercially available, high-sensitivity kit. The results are reliable, consistent, and correlate very well with the blood measurements.</p><p>This innovation has allowed for studies to be performed on the effects of spaceflight (short: 10&#x02013;16 days and long: up to 1 year) on cortisol and DHEA levels, two important stress and immune regulatory hormones, on multiple spaceflight timepoints, as well as the study of the effects of the circadian rhythm on these hormones in this unique environment [<xref rid="B19-viruses-16-01909" ref-type="bibr">19</xref>,<xref rid="B20-viruses-16-01909" ref-type="bibr">20</xref>]. Cortisol regulates the body&#x02019;s stress response and helps suppress inflammation, while DHEA counterbalances cortisol by enhancing immunity and promoting anabolic effects. The molar ratio of cortisol to DHEA [C]/[D] is thus often used as a vital marker of immune regulation and stress response homeostasis. Using the SPIT booklets in these flight studies, we analyzed the regular diurnal release of these hormones through the various phases of flight: pre-, in-, and post-flight [<xref rid="B20-viruses-16-01909" ref-type="bibr">20</xref>]. The diurnal patterns of salivary cortisol were elevated during flight, while DHEA was reduced. Thus, we have observed through this saliva collection technology an increased [C]/[D] ratio during spaceflight (<xref rid="viruses-16-01909-f002" ref-type="fig">Figure 2</xref>), suggesting potential challenges to the immune system while astronauts are in space. The salivary hormone data from these studies have been linked to a broader immune modulation [<xref rid="B50-viruses-16-01909" ref-type="bibr">50</xref>], including increased inflammatory cytokine response and TH2 shift observed in plasma samples from earlier spaceflight studies [<xref rid="B18-viruses-16-01909" ref-type="bibr">18</xref>,<xref rid="B51-viruses-16-01909" ref-type="bibr">51</xref>].</p></sec><sec id="sec5-viruses-16-01909"><title>5. Saliva for Immunology Biomarkers</title><p>Saliva samples can be very informative, for research or clinical purposes, for a variety of immune system biomarkers. Cytokine concentration is an excellent indicator of the hormonal regulation of immunity, inflammation, Th1/2 shifts, and other processes. We have previously published saliva cytokine alterations in ISS crewmembers [<xref rid="B17-viruses-16-01909" ref-type="bibr">17</xref>]. In congruence with a study performed on healthy subjects [<xref rid="B52-viruses-16-01909" ref-type="bibr">52</xref>], we observed correlations between salivary and plasma IL-6 and IFN-&#x003b3; in astronaut samples before, during, and after spaceflight. Williamson et al. further reported correlations with MIP-1&#x003b2;, while our study in astronauts included correlations in IL-8 and IL-12p70. The relatively low number of correlations (5/27) between saliva and plasma is not unexpected, however, considering the study populations in these studies: healthy adults and highly selected, physically fit astronauts. Given the abundance of IL-6, IFN-&#x003b3;, MIP-1&#x003b2;, and IL-8 in normal physiological states, the correlations between the saliva and plasma of these cytokines are logical. Conversely, low to normal levels of other remote cytokines in plasma may not consistently and passively diffuse across the BSB and show up regularly in saliva. The successful measurement of at least 27 cytokines in these studies provides validation that saliva could be used as a platform for both the assessment and longitudinal tracking of cytokine levels in both research and clinical disease studies. Furthermore, in another study on ISS crewmembers and ground controls, saliva was used to assess a variety of first-line innate immune antimicrobial defenses [<xref rid="B12-viruses-16-01909" ref-type="bibr">12</xref>]. These findings from saliva analysis furthered the evidence that spaceflight can impact the immune system of astronauts. In addition, we have established protocols that enable the collection, storage, and recovery of saliva cytokines for up to 1+ years (unpublished data). Other potential targets for saliva monitoring include antibody concentrations (i.e., SARS-COV-2 anti-spike Igs [<xref rid="B53-viruses-16-01909" ref-type="bibr">53</xref>]), both generic and pathogen-specific, antimicrobial proteins, and general markers of inflammation (CRP, etc.).</p></sec><sec id="sec6-viruses-16-01909"><title>6. Saliva for Other Biomarkers</title><p>Saliva has the potential to be valuable in monitoring other types of biomarkers. These include markers of bone function and markers of nutritional status. Cardiovascular disease may be informed by measuring CKMB or myoglobin. Measurements of HbA1C can give information about diabetes risk. Leptin and ghrelin are hormones produced by the salivary glands that are involved with the regulation of body weight, energy balance, and glucose metabolism [<xref rid="B54-viruses-16-01909" ref-type="bibr">54</xref>,<xref rid="B55-viruses-16-01909" ref-type="bibr">55</xref>]. A variety of growth factors like insulin-like growth factor 1 (IGF-1) and epidermal growth factor (EGF) have also been measured in saliva, indicating their use as biomarkers of bone, tissue, and cellular synthesis [<xref rid="B56-viruses-16-01909" ref-type="bibr">56</xref>]. Heat shock protein 70 (HSP70) is a protein that is also detected in saliva and involved in the signaling networks for immune cells to release pro-inflammatory cytokines. This protein is a stress-induced protein involved in several pathological conditions, including autoimmune diseases such as arthritis, dermatitis, Guillan&#x02013;Barre syndrome, and systemic lupus; the use of saliva samples would serve as a non-invasive, cost-effective method for the detection of some of these conditions [<xref rid="B57-viruses-16-01909" ref-type="bibr">57</xref>]. Heat shock protein 47 (HSP47), which is involved in the regulation of collagen maturation, is also detected in the saliva [<xref rid="B58-viruses-16-01909" ref-type="bibr">58</xref>]. Infectious diseases may be informed not just by the measurement of virus DNA but by the detection of a wide variety of other pathogens, including bacteria or fungi. Further, it may be possible to develop the isolation and characterization of intact cells, either endothelial (latent virus DNA, as we have previously published) or immune cells (neutrophils, lymphocytes, etc.), to inform other types of physiological dysregulation or disease processes.</p></sec><sec sec-type="conclusions" id="sec7-viruses-16-01909"><title>7. Conclusions</title><p>To illustrate the advantage of using saliva in clinical research, in one recent study we conducted [<xref rid="B59-viruses-16-01909" ref-type="bibr">59</xref>], saliva was used to determine the effectiveness of the prophylactic administration of an antiviral drug (valacyclovir) as a countermeasure to herpesvirus shedding and reactivation in Antarctic expeditioners. Briefly, the subjects were either given valacyclovir or a placebo every day for the duration of their mission (6&#x02013;8 months). The viral shedding, in terms of both viral load and frequency, was remarkably reduced for both EBV and HSV-1 in the treatment group, while the reactivation of VZV was not detected in any sample. Additionally, saliva supernatants were used to assess traditional stress markers (DHEA, cortisol, and alpha-amylase) and the 13-plex cytokine immune profile of the expeditioners. Essentially, no difference was seen in the stress hormones, whereas many cytokines were suppressed. Further, additional immunological markers are currently being assessed with the remaining frozen volumes (unpublished to date). This experiment truly encompasses the unique benefit that analyzing saliva can have for diagnostic purposes. For instance, for 6&#x02013;8 months at stations in Antarctica (McMurdo or South Pole), a saliva sample was donated for 5 straight days every month by over 30 individual subjects, highlighting its ease of use in a longitudinal study. The efficiency of the sampling process maintained subject adherence to the protocols and limited study dropouts. Over a thousand samples were easily collected, stored, and frozen by the subjects until shipment by the study coordinators to Johnson Space Center, limiting the need for specialized equipment and personnel. A wide variety of analytes were assessed from each sample, covering three different scientific disciplines of virology, stress, and immunology. While blood sampling may have been feasible insofar as budget, time, expertise, and resources allow, it would not have been as easy and inexpensive as saliva while covering fundamentally the same analyses.</p><p>There is clearly more to saliva than its physical properties of moistening and protecting the oral cavity. Overall, saliva represents an important physiological fluid that comprises a complex mixture of analytes, including viruses, enzymes, hormones, nucleic acids, proteins, immune markers, minerals, and cells. Beneficially, these secretions into saliva can also be used for biomarker detection in clinical diagnostics for not only virology but a wealth of other scientific disciplines. Its non-invasive and simplistic self-collection procedures make it an attractive stress-free diagnostic fluid with minimal processing requirements (both in liquid and dry storage form) to study a variety of normal and disease states in spaceflight research and beyond.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors are very thankful to the astronauts who participated in these spaceflight studies.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-viruses-16-01909"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shang</surname><given-names>Y.F.</given-names></name>
<name><surname>Shen</surname><given-names>Y.Y.</given-names></name>
<name><surname>Zhang</surname><given-names>M.C.</given-names></name>
<name><surname>Lv</surname><given-names>M.C.</given-names></name>
<name><surname>Wang</surname><given-names>T.Y.</given-names></name>
<name><surname>Chen</surname><given-names>X.Q.</given-names></name>
<name><surname>Lin</surname><given-names>J.</given-names></name>
</person-group><article-title>Progress in salivary glands: Endocrine glands with immune functions</article-title><source>Front. Endocrinol.</source><year>2023</year><volume>14</volume><elocation-id>1061235</elocation-id><pub-id pub-id-type="doi">10.3389/fendo.2023.1061235</pub-id><pub-id pub-id-type="pmid">36817607</pub-id>
</element-citation></ref><ref id="B2-viruses-16-01909"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bierbaumer</surname><given-names>L.</given-names></name>
<name><surname>Schwarze</surname><given-names>U.Y.</given-names></name>
<name><surname>Gruber</surname><given-names>R.</given-names></name>
<name><surname>Neuhaus</surname><given-names>W.</given-names></name>
</person-group><article-title>Cell culture models of oral mucosal barriers: A review with a focus on applications, culture conditions and barrier properties</article-title><source>Tissue Barriers</source><year>2018</year><volume>6</volume><fpage>1479568</fpage><pub-id pub-id-type="doi">10.1080/21688370.2018.1479568</pub-id><pub-id pub-id-type="pmid">30252599</pub-id>
</element-citation></ref><ref id="B3-viruses-16-01909"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lin</surname><given-names>G.C.</given-names></name>
<name><surname>K&#x000fc;ng</surname><given-names>E.</given-names></name>
<name><surname>Smajlhodzic</surname><given-names>M.</given-names></name>
<name><surname>Domazet</surname><given-names>S.</given-names></name>
<name><surname>Friedl</surname><given-names>H.P.</given-names></name>
<name><surname>Angerer</surname><given-names>J.</given-names></name>
<name><surname>Wisgrill</surname><given-names>L.</given-names></name>
<name><surname>Berger</surname><given-names>A.</given-names></name>
<name><surname>Bingle</surname><given-names>L.</given-names></name>
<name><surname>Peham</surname><given-names>J.R.</given-names></name>
<etal/>
</person-group><article-title>Directed Transport of CRP Across In Vitro Models of the Blood-Saliva Barrier Strengthens the Feasibility of Salivary CRP as Biomarker for Neonatal Sepsis</article-title><source>Pharmaceutics</source><year>2021</year><volume>13</volume><elocation-id>256</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics13020256</pub-id><pub-id pub-id-type="pmid">33673378</pub-id>
</element-citation></ref><ref id="B4-viruses-16-01909"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>J.M.</given-names></name>
<name><surname>Garon</surname><given-names>E.</given-names></name>
<name><surname>Wong</surname><given-names>D.T.</given-names></name>
</person-group><article-title>Salivary diagnostics</article-title><source>Orthod. Craniofac. Res.</source><year>2009</year><volume>12</volume><fpage>206</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1111/j.1601-6343.2009.01454.x</pub-id><pub-id pub-id-type="pmid">19627522</pub-id>
</element-citation></ref><ref id="B5-viruses-16-01909"><label>5.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Thomas</surname><given-names>E.A.</given-names></name>
</person-group><article-title>Therapeutic Drug Monitoring in Saliva</article-title><source>Salivary Bioscience: Foundations of Interdisciplinary Saliva Research and Applications</source><person-group person-group-type="editor">
<name><surname>Granger</surname><given-names>D.A.</given-names></name>
<name><surname>Taylor</surname><given-names>M.K.</given-names></name>
</person-group><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham, Switzerland</publisher-loc><year>2020</year><fpage>395</fpage><lpage>417</lpage></element-citation></ref><ref id="B6-viruses-16-01909"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mandel</surname><given-names>I.D.</given-names></name>
</person-group><article-title>Salivary diagnosis: More than a lick and a promise</article-title><source>J. Am. Dent. Assoc.</source><year>1993</year><volume>124</volume><fpage>85</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.14219/jada.archive.1993.0007</pub-id><pub-id pub-id-type="pmid">8445148</pub-id>
</element-citation></ref><ref id="B7-viruses-16-01909"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Coopman</surname><given-names>R.</given-names></name>
<name><surname>Speeckaert</surname><given-names>M.M.</given-names></name>
<name><surname>Aps</surname><given-names>J.K.</given-names></name>
<name><surname>Delanghe</surname><given-names>J.R.</given-names></name>
</person-group><article-title>Flow cytometry-based analysis by Sysmex-UF1000i<sup>&#x000ae;</sup> is an alternative method in the assessment of periodontal inflammation</article-title><source>Clin. Chim. Acta</source><year>2014</year><volume>436</volume><fpage>176</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1016/j.cca.2014.05.021</pub-id><pub-id pub-id-type="pmid">24907666</pub-id>
</element-citation></ref><ref id="B8-viruses-16-01909"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lalibert&#x000e9;</surname><given-names>C.</given-names></name>
<name><surname>Ng</surname><given-names>N.</given-names></name>
<name><surname>Eymael</surname><given-names>D.</given-names></name>
<name><surname>Higgins</surname><given-names>K.</given-names></name>
<name><surname>Ali</surname><given-names>A.</given-names></name>
<name><surname>Kiss</surname><given-names>A.</given-names></name>
<name><surname>Bradley</surname><given-names>G.</given-names></name>
<name><surname>Magalhaes</surname><given-names>M.A.O.</given-names></name>
</person-group><article-title>Characterization of Oral Squamous Cell Carcinoma Associated Inflammation: A Pilot Study</article-title><source>Front. Oral Health</source><year>2021</year><volume>2</volume><elocation-id>740469</elocation-id><pub-id pub-id-type="doi">10.3389/froh.2021.740469</pub-id><pub-id pub-id-type="pmid">35048057</pub-id>
</element-citation></ref><ref id="B9-viruses-16-01909"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kinloch</surname><given-names>N.N.</given-names></name>
<name><surname>Ritchie</surname><given-names>G.</given-names></name>
<name><surname>Brumme</surname><given-names>C.J.</given-names></name>
<name><surname>Dong</surname><given-names>W.</given-names></name>
<name><surname>Dong</surname><given-names>W.</given-names></name>
<name><surname>Lawson</surname><given-names>T.</given-names></name>
<name><surname>Jones</surname><given-names>R.B.</given-names></name>
<name><surname>Montaner</surname><given-names>J.S.G.</given-names></name>
<name><surname>Leung</surname><given-names>V.</given-names></name>
<name><surname>Romney</surname><given-names>M.G.</given-names></name>
<etal/>
</person-group><article-title>Suboptimal Biological Sampling as a Probable Cause of False-Negative COVID-19 Diagnostic Test Results</article-title><source>J. Infect. Dis.</source><year>2020</year><volume>222</volume><fpage>899</fpage><lpage>902</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiaa370</pub-id><pub-id pub-id-type="pmid">32594170</pub-id>
</element-citation></ref><ref id="B10-viruses-16-01909"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>D.H.</given-names></name>
<name><surname>Basurrah</surname><given-names>M.A.</given-names></name>
<name><surname>Han</surname><given-names>J.H.</given-names></name>
<name><surname>Kim</surname><given-names>S.W.</given-names></name>
<name><surname>Hwang</surname><given-names>S.H.</given-names></name>
</person-group><article-title>The diagnostic accuracy of RT-PCR from self-collected saliva versus nasopharyngeal sampling: A systematic review and meta-analysis</article-title><source>Saudi Med. J.</source><year>2022</year><volume>43</volume><fpage>9</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.15537/smj.2022.43.1.20210743</pub-id><pub-id pub-id-type="pmid">35022280</pub-id>
</element-citation></ref><ref id="B11-viruses-16-01909"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ghosh</surname><given-names>S.</given-names></name>
<name><surname>Dhobley</surname><given-names>A.</given-names></name>
<name><surname>Avula</surname><given-names>K.K.</given-names></name>
<name><surname>Joseph</surname><given-names>S.</given-names></name>
<name><surname>Gavali</surname><given-names>N.</given-names></name>
<name><surname>Sinha</surname><given-names>S.</given-names></name>
</person-group><article-title>Role of Saliva as a Non-Invasive Diagnostic Method for Detection of COVID-19</article-title><source>Cureus</source><year>2022</year><volume>14</volume><fpage>e27471</fpage><pub-id pub-id-type="doi">10.7759/cureus.27471</pub-id><pub-id pub-id-type="pmid">36060364</pub-id>
</element-citation></ref><ref id="B12-viruses-16-01909"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Agha</surname><given-names>N.H.</given-names></name>
<name><surname>Baker</surname><given-names>F.L.</given-names></name>
<name><surname>Kunz</surname><given-names>H.E.</given-names></name>
<name><surname>Spielmann</surname><given-names>G.</given-names></name>
<name><surname>Mylabathula</surname><given-names>P.L.</given-names></name>
<name><surname>Rooney</surname><given-names>B.V.</given-names></name>
<name><surname>Mehta</surname><given-names>S.K.</given-names></name>
<name><surname>Pierson</surname><given-names>D.L.</given-names></name>
<name><surname>Laughlin</surname><given-names>M.S.</given-names></name>
<name><surname>Markofski</surname><given-names>M.M.</given-names></name>
<etal/>
</person-group><article-title>Salivary antimicrobial proteins and stress biomarkers are elevated during a 6-month mission to the International Space Station</article-title><source>J. Appl. Physiol.</source><year>2020</year><volume>128</volume><fpage>264</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00560.2019</pub-id><pub-id pub-id-type="pmid">31751178</pub-id>
</element-citation></ref><ref id="B13-viruses-16-01909"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Agha</surname><given-names>N.H.</given-names></name>
<name><surname>Mehta</surname><given-names>S.K.</given-names></name>
<name><surname>Rooney</surname><given-names>B.V.</given-names></name>
<name><surname>Laughlin</surname><given-names>M.S.</given-names></name>
<name><surname>Markofski</surname><given-names>M.M.</given-names></name>
<name><surname>Pierson</surname><given-names>D.L.</given-names></name>
<name><surname>Katsanis</surname><given-names>E.</given-names></name>
<name><surname>Crucian</surname><given-names>B.E.</given-names></name>
<name><surname>Simpson</surname><given-names>R.J.</given-names></name>
</person-group><article-title>Exercise as a countermeasure for latent viral reactivation during long duration space flight</article-title><source>FASEB J.</source><year>2020</year><volume>34</volume><fpage>2869</fpage><lpage>2881</lpage><pub-id pub-id-type="doi">10.1096/fj.201902327R</pub-id><pub-id pub-id-type="pmid">31908052</pub-id>
</element-citation></ref><ref id="B14-viruses-16-01909"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cohrs</surname><given-names>R.J.</given-names></name>
<name><surname>Mehta</surname><given-names>S.K.</given-names></name>
<name><surname>Schmid</surname><given-names>D.S.</given-names></name>
<name><surname>Gilden</surname><given-names>D.H.</given-names></name>
<name><surname>Pierson</surname><given-names>D.L.</given-names></name>
</person-group><article-title>Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts</article-title><source>J. Med. Virol.</source><year>2008</year><volume>80</volume><fpage>1116</fpage><lpage>1122</lpage><pub-id pub-id-type="doi">10.1002/jmv.21173</pub-id><pub-id pub-id-type="pmid">18428120</pub-id>
</element-citation></ref><ref id="B15-viruses-16-01909"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Crucian</surname><given-names>B.E.</given-names></name>
<name><surname>Stowe</surname><given-names>R.P.</given-names></name>
<name><surname>Mehta</surname><given-names>S.K.</given-names></name>
<name><surname>Yetman</surname><given-names>D.L.</given-names></name>
<name><surname>Leal</surname><given-names>M.J.</given-names></name>
<name><surname>Quiriarte</surname><given-names>H.D.</given-names></name>
<name><surname>Pierson</surname><given-names>D.L.</given-names></name>
<name><surname>Sams</surname><given-names>C.F.</given-names></name>
</person-group><article-title>Immune status, latent viral reactivation, and stress during long-duration head-down bed rest</article-title><source>Aviat. Space Environ. Med.</source><year>2009</year><volume>80</volume><fpage>A37</fpage><lpage>A44</lpage><pub-id pub-id-type="doi">10.3357/ASEM.BR05.2009</pub-id><pub-id pub-id-type="pmid">19476168</pub-id>
</element-citation></ref><ref id="B16-viruses-16-01909"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Diak</surname><given-names>D.M.</given-names></name>
<name><surname>Krieger</surname><given-names>S.</given-names></name>
<name><surname>Gutierrez</surname><given-names>C.</given-names></name>
<name><surname>Mehta</surname><given-names>S.</given-names></name>
<name><surname>Nelman-Gonzalez</surname><given-names>M.</given-names></name>
<name><surname>Babiak-Vazquez</surname><given-names>A.</given-names></name>
<name><surname>Young</surname><given-names>M.</given-names></name>
<name><surname>Oswald</surname><given-names>T.M.</given-names></name>
<name><surname>Chouk&#x000e9;r</surname><given-names>A.</given-names></name>
<name><surname>Johnson</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Palmer Station, Antarctica: A ground-based spaceflight analog suitable for validation of biomedical countermeasures for deep space missions</article-title><source>Life Sci. Space Res.</source><year>2024</year><volume>40</volume><fpage>151</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/j.lssr.2023.08.001</pub-id></element-citation></ref><ref id="B17-viruses-16-01909"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Krieger</surname><given-names>S.S.</given-names></name>
<name><surname>Zwart</surname><given-names>S.R.</given-names></name>
<name><surname>Mehta</surname><given-names>S.</given-names></name>
<name><surname>Wu</surname><given-names>H.</given-names></name>
<name><surname>Simpson</surname><given-names>R.J.</given-names></name>
<name><surname>Smith</surname><given-names>S.M.</given-names></name>
<name><surname>Crucian</surname><given-names>B.</given-names></name>
</person-group><article-title>Alterations in Saliva and Plasma Cytokine Concentrations During Long-Duration Spaceflight</article-title><source>Front. Immunol.</source><year>2021</year><volume>12</volume><elocation-id>725748</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2021.725748</pub-id><pub-id pub-id-type="pmid">34504500</pub-id>
</element-citation></ref><ref id="B18-viruses-16-01909"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mehta</surname><given-names>S.K.</given-names></name>
<name><surname>Crucian</surname><given-names>B.E.</given-names></name>
<name><surname>Stowe</surname><given-names>R.P.</given-names></name>
<name><surname>Simpson</surname><given-names>R.J.</given-names></name>
<name><surname>Ott</surname><given-names>C.M.</given-names></name>
<name><surname>Sams</surname><given-names>C.F.</given-names></name>
<name><surname>Pierson</surname><given-names>D.L.</given-names></name>
</person-group><article-title>Reactivation of latent viruses is associated with increased plasma cytokines in astronauts</article-title><source>Cytokine</source><year>2013</year><volume>61</volume><fpage>205</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1016/j.cyto.2012.09.019</pub-id><pub-id pub-id-type="pmid">23107825</pub-id>
</element-citation></ref><ref id="B19-viruses-16-01909"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mehta</surname><given-names>S.K.</given-names></name>
<name><surname>Laudenslager</surname><given-names>M.L.</given-names></name>
<name><surname>Stowe</surname><given-names>R.P.</given-names></name>
<name><surname>Crucian</surname><given-names>B.E.</given-names></name>
<name><surname>Feiveson</surname><given-names>A.H.</given-names></name>
<name><surname>Sams</surname><given-names>C.F.</given-names></name>
<name><surname>Pierson</surname><given-names>D.L.</given-names></name>
</person-group><article-title>Latent virus reactivation in astronauts on the international space station</article-title><source>NPJ Microgravity</source><year>2017</year><volume>3</volume><fpage>11</fpage><pub-id pub-id-type="doi">10.1038/s41526-017-0015-y</pub-id><pub-id pub-id-type="pmid">28649633</pub-id>
</element-citation></ref><ref id="B20-viruses-16-01909"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mehta</surname><given-names>S.K.</given-names></name>
<name><surname>Laudenslager</surname><given-names>M.L.</given-names></name>
<name><surname>Stowe</surname><given-names>R.P.</given-names></name>
<name><surname>Crucian</surname><given-names>B.E.</given-names></name>
<name><surname>Sams</surname><given-names>C.F.</given-names></name>
<name><surname>Pierson</surname><given-names>D.L.</given-names></name>
</person-group><article-title>Multiple latent viruses reactivate in astronauts during Space Shuttle missions</article-title><source>Brain Behav. Immun.</source><year>2014</year><volume>41</volume><fpage>210</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/j.bbi.2014.05.014</pub-id><pub-id pub-id-type="pmid">24886968</pub-id>
</element-citation></ref><ref id="B21-viruses-16-01909"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rooney</surname><given-names>B.V.</given-names></name>
<name><surname>Crucian</surname><given-names>B.E.</given-names></name>
<name><surname>Pierson</surname><given-names>D.L.</given-names></name>
<name><surname>Laudenslager</surname><given-names>M.L.</given-names></name>
<name><surname>Mehta</surname><given-names>S.K.</given-names></name>
</person-group><article-title>Herpes Virus Reactivation in Astronauts During Spaceflight and Its Application on Earth</article-title><source>Front. Microbiol.</source><year>2019</year><volume>10</volume><elocation-id>16</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2019.00016</pub-id><pub-id pub-id-type="pmid">30792698</pub-id>
</element-citation></ref><ref id="B22-viruses-16-01909"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Segal</surname><given-names>A.</given-names></name>
<name><surname>Wong</surname><given-names>D.T.</given-names></name>
</person-group><article-title>Salivary diagnostics: Enhancing disease detection and making medicine better</article-title><source>Eur. J. Dent. Educ.</source><year>2008</year><volume>12</volume><issue>(Suppl. 1)</issue><fpage>22</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0579.2007.00477.x</pub-id><pub-id pub-id-type="pmid">18289265</pub-id>
</element-citation></ref><ref id="B23-viruses-16-01909"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Neu</surname><given-names>M.</given-names></name>
<name><surname>Goldstein</surname><given-names>M.</given-names></name>
<name><surname>Gao</surname><given-names>D.</given-names></name>
<name><surname>Laudenslager</surname><given-names>M.L.</given-names></name>
</person-group><article-title>Salivary cortisol in preterm infants: Validation of a simple method for collecting saliva for cortisol determination</article-title><source>Early Hum. Dev.</source><year>2007</year><volume>83</volume><fpage>47</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.earlhumdev.2006.04.003</pub-id><pub-id pub-id-type="pmid">16766144</pub-id>
</element-citation></ref><ref id="B24-viruses-16-01909"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hofman</surname><given-names>L.F.</given-names></name>
</person-group><article-title>Human saliva as a diagnostic specimen</article-title><source>J. Nutr.</source><year>2001</year><volume>131</volume><fpage>1621s</fpage><lpage>1625s</lpage><pub-id pub-id-type="doi">10.1093/jn/131.5.1621S</pub-id><pub-id pub-id-type="pmid">11340128</pub-id>
</element-citation></ref><ref id="B25-viruses-16-01909"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Plomp</surname><given-names>R.</given-names></name>
<name><surname>de Haan</surname><given-names>N.</given-names></name>
<name><surname>Bondt</surname><given-names>A.</given-names></name>
<name><surname>Murli</surname><given-names>J.</given-names></name>
<name><surname>Dotz</surname><given-names>V.</given-names></name>
<name><surname>Wuhrer</surname><given-names>M.</given-names></name>
</person-group><article-title>Comparative Glycomics of Immunoglobulin A and G From Saliva and Plasma Reveals Biomarker Potential</article-title><source>Front. Immunol.</source><year>2018</year><volume>9</volume><elocation-id>02436</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.02436</pub-id><pub-id pub-id-type="pmid">30405629</pub-id>
</element-citation></ref><ref id="B26-viruses-16-01909"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hettegger</surname><given-names>P.</given-names></name>
<name><surname>Huber</surname><given-names>J.</given-names></name>
<name><surname>Pa&#x000df;ecker</surname><given-names>K.</given-names></name>
<name><surname>Soldo</surname><given-names>R.</given-names></name>
<name><surname>Kegler</surname><given-names>U.</given-names></name>
<name><surname>N&#x000f6;hammer</surname><given-names>C.</given-names></name>
<name><surname>Weinh&#x000e4;usel</surname><given-names>A.</given-names></name>
</person-group><article-title>High similarity of IgG antibody profiles in blood and saliva opens opportunities for saliva based serology</article-title><source>PLoS ONE</source><year>2019</year><volume>14</volume><elocation-id>e0218456</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0218456</pub-id><pub-id pub-id-type="pmid">31220138</pub-id>
</element-citation></ref><ref id="B27-viruses-16-01909"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Akula</surname><given-names>S.</given-names></name>
<name><surname>Welinder</surname><given-names>C.</given-names></name>
<name><surname>Fu</surname><given-names>Z.</given-names></name>
<name><surname>Olsson</surname><given-names>A.K.</given-names></name>
<name><surname>Hellman</surname><given-names>L.</given-names></name>
</person-group><article-title>Identification of the Major Protein Components of Human and Cow Saliva</article-title><source>Int. J. Mol. Sci.</source><year>2023</year><volume>24</volume><elocation-id>16838</elocation-id><pub-id pub-id-type="doi">10.3390/ijms242316838</pub-id><pub-id pub-id-type="pmid">38069163</pub-id>
</element-citation></ref><ref id="B28-viruses-16-01909"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Castagnola</surname><given-names>M.</given-names></name>
<name><surname>Scarano</surname><given-names>E.</given-names></name>
<name><surname>Passali</surname><given-names>G.C.</given-names></name>
<name><surname>Messana</surname><given-names>I.</given-names></name>
<name><surname>Cabras</surname><given-names>T.</given-names></name>
<name><surname>Iavarone</surname><given-names>F.</given-names></name>
<name><surname>Di Cintio</surname><given-names>G.</given-names></name>
<name><surname>Fiorita</surname><given-names>A.</given-names></name>
<name><surname>De Corso</surname><given-names>E.</given-names></name>
<name><surname>Paludetti</surname><given-names>G.</given-names></name>
</person-group><article-title>Salivary biomarkers and proteomics: Future diagnostic and clinical utilities</article-title><source>Acta Otorhinolaryngol. Ital.</source><year>2017</year><volume>37</volume><fpage>94</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.14639/0392-100X-1598</pub-id><pub-id pub-id-type="pmid">28516971</pub-id>
</element-citation></ref><ref id="B29-viruses-16-01909"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Whembolua</surname><given-names>G.L.</given-names></name>
<name><surname>Granger</surname><given-names>D.A.</given-names></name>
<name><surname>Singer</surname><given-names>S.</given-names></name>
<name><surname>Kivlighan</surname><given-names>K.T.</given-names></name>
<name><surname>Marguin</surname><given-names>J.A.</given-names></name>
</person-group><article-title>Bacteria in the oral mucosa and its effects on the measurement of cortisol, dehydroepiandrosterone, and testosterone in saliva</article-title><source>Horm. Behav.</source><year>2006</year><volume>49</volume><fpage>478</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1016/j.yhbeh.2005.10.005</pub-id><pub-id pub-id-type="pmid">16309679</pub-id>
</element-citation></ref><ref id="B30-viruses-16-01909"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thomadaki</surname><given-names>K.</given-names></name>
<name><surname>Helmerhorst</surname><given-names>E.J.</given-names></name>
<name><surname>Tian</surname><given-names>N.</given-names></name>
<name><surname>Sun</surname><given-names>X.</given-names></name>
<name><surname>Siqueira</surname><given-names>W.L.</given-names></name>
<name><surname>Walt</surname><given-names>D.R.</given-names></name>
<name><surname>Oppenheim</surname><given-names>F.G.</given-names></name>
</person-group><article-title>Whole-saliva proteolysis and its impact on salivary diagnostics</article-title><source>J. Dent. Res.</source><year>2011</year><volume>90</volume><fpage>1325</fpage><lpage>1330</lpage><pub-id pub-id-type="doi">10.1177/0022034511420721</pub-id><pub-id pub-id-type="pmid">21917601</pub-id>
</element-citation></ref><ref id="B31-viruses-16-01909"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Esser</surname><given-names>D.</given-names></name>
<name><surname>Alvarez-Llamas</surname><given-names>G.</given-names></name>
<name><surname>de Vries</surname><given-names>M.P.</given-names></name>
<name><surname>Weening</surname><given-names>D.</given-names></name>
<name><surname>Vonk</surname><given-names>R.J.</given-names></name>
<name><surname>Roelofsen</surname><given-names>H.</given-names></name>
</person-group><article-title>Sample Stability and Protein Composition of Saliva: Implications for Its Use as a Diagnostic Fluid</article-title><source>Biomark. Insights</source><year>2008</year><volume>3</volume><fpage>25</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.4137/BMI.S607</pub-id><pub-id pub-id-type="pmid">19578491</pub-id>
</element-citation></ref><ref id="B32-viruses-16-01909"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Burrows</surname><given-names>A.M.</given-names></name>
<name><surname>Ristow</surname><given-names>P.G.</given-names></name>
<name><surname>D&#x02019;Amato</surname><given-names>M.E.</given-names></name>
</person-group><article-title>Preservation of DNA from saliva samples in suboptimal conditions</article-title><source>Forensic Sci. Int. Genet. Suppl. Ser.</source><year>2017</year><volume>6</volume><fpage>e80</fpage><lpage>e81</lpage><pub-id pub-id-type="doi">10.1016/j.fsigss.2017.09.050</pub-id></element-citation></ref><ref id="B33-viruses-16-01909"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mehta</surname><given-names>S.K.</given-names></name>
<name><surname>Cohrs</surname><given-names>R.J.</given-names></name>
<name><surname>Forghani</surname><given-names>B.</given-names></name>
<name><surname>Zerbe</surname><given-names>G.</given-names></name>
<name><surname>Gilden</surname><given-names>D.H.</given-names></name>
<name><surname>Pierson</surname><given-names>D.L.</given-names></name>
</person-group><article-title>Stress-induced subclinical reactivation of varicella zoster virus in astronauts</article-title><source>J. Med. Virol.</source><year>2004</year><volume>72</volume><fpage>174</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1002/jmv.10555</pub-id><pub-id pub-id-type="pmid">14635028</pub-id>
</element-citation></ref><ref id="B34-viruses-16-01909"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mehta</surname><given-names>S.K.</given-names></name>
<name><surname>Pierson</surname><given-names>D.L.</given-names></name>
<name><surname>Cooley</surname><given-names>H.</given-names></name>
<name><surname>Dubow</surname><given-names>R.</given-names></name>
<name><surname>Lugg</surname><given-names>D.</given-names></name>
</person-group><article-title>Epstein-Barr virus reactivation associated with diminished cell-mediated immunity in antarctic expeditioners</article-title><source>J. Med. Virol.</source><year>2000</year><volume>61</volume><fpage>235</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-9071(200006)61:2&#x0003c;235::AID-JMV10&#x0003e;3.0.CO;2-4</pub-id><pub-id pub-id-type="pmid">10797380</pub-id>
</element-citation></ref><ref id="B35-viruses-16-01909"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Payne</surname><given-names>D.A.</given-names></name>
<name><surname>Mehta</surname><given-names>S.K.</given-names></name>
<name><surname>Tyring</surname><given-names>S.K.</given-names></name>
<name><surname>Stowe</surname><given-names>R.P.</given-names></name>
<name><surname>Pierson</surname><given-names>D.L.</given-names></name>
</person-group><article-title>Incidence of Epstein-Barr virus in astronaut saliva during spaceflight</article-title><source>Aviat. Space Environ. Med.</source><year>1999</year><volume>70</volume><fpage>1211</fpage><lpage>1213</lpage><pub-id pub-id-type="pmid">10596777</pub-id>
</element-citation></ref><ref id="B36-viruses-16-01909"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pierson</surname><given-names>D.L.</given-names></name>
<name><surname>Stowe</surname><given-names>R.P.</given-names></name>
<name><surname>Phillips</surname><given-names>T.M.</given-names></name>
<name><surname>Lugg</surname><given-names>D.J.</given-names></name>
<name><surname>Mehta</surname><given-names>S.K.</given-names></name>
</person-group><article-title>Epstein-Barr virus shedding by astronauts during space flight</article-title><source>Brain Behav. Immun.</source><year>2005</year><volume>19</volume><fpage>235</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1016/j.bbi.2004.08.001</pub-id><pub-id pub-id-type="pmid">15797312</pub-id>
</element-citation></ref><ref id="B37-viruses-16-01909"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mehta</surname><given-names>S.K.</given-names></name>
<name><surname>Stowe</surname><given-names>R.P.</given-names></name>
<name><surname>Feiveson</surname><given-names>A.H.</given-names></name>
<name><surname>Tyring</surname><given-names>S.K.</given-names></name>
<name><surname>Pierson</surname><given-names>D.L.</given-names></name>
</person-group><article-title>Reactivation and shedding of cytomegalovirus in astronauts during spaceflight</article-title><source>J. Infect. Dis.</source><year>2000</year><volume>182</volume><fpage>1761</fpage><lpage>1764</lpage><pub-id pub-id-type="doi">10.1086/317624</pub-id><pub-id pub-id-type="pmid">11069250</pub-id>
</element-citation></ref><ref id="B38-viruses-16-01909"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mehta</surname><given-names>S.K.</given-names></name>
<name><surname>Szpara</surname><given-names>M.L.</given-names></name>
<name><surname>Rooney</surname><given-names>B.V.</given-names></name>
<name><surname>Diak</surname><given-names>D.M.</given-names></name>
<name><surname>Shipley</surname><given-names>M.M.</given-names></name>
<name><surname>Renner</surname><given-names>D.W.</given-names></name>
<name><surname>Krieger</surname><given-names>S.S.</given-names></name>
<name><surname>Nelman-Gonzalez</surname><given-names>M.A.</given-names></name>
<name><surname>Zwart</surname><given-names>S.R.</given-names></name>
<name><surname>Smith</surname><given-names>S.M.</given-names></name>
<etal/>
</person-group><article-title>Dermatitis during Spaceflight Associated with HSV-1 Reactivation</article-title><source>Viruses</source><year>2022</year><volume>14</volume><elocation-id>789</elocation-id><pub-id pub-id-type="doi">10.3390/v14040789</pub-id><pub-id pub-id-type="pmid">35458519</pub-id>
</element-citation></ref><ref id="B39-viruses-16-01909"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gilden</surname><given-names>D.H.</given-names></name>
<name><surname>Gesser</surname><given-names>R.</given-names></name>
<name><surname>Smith</surname><given-names>J.</given-names></name>
<name><surname>Wellish</surname><given-names>M.</given-names></name>
<name><surname>Laguardia</surname><given-names>J.J.</given-names></name>
<name><surname>Cohrs</surname><given-names>R.J.</given-names></name>
<name><surname>Mahalingam</surname><given-names>R.</given-names></name>
</person-group><article-title>Presence of VZV and HSV-1 DNA in human nodose and celiac ganglia</article-title><source>Virus Genes</source><year>2001</year><volume>23</volume><fpage>145</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1023/A:1011883919058</pub-id><pub-id pub-id-type="pmid">11724266</pub-id>
</element-citation></ref><ref id="B40-viruses-16-01909"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mahalingam</surname><given-names>R.</given-names></name>
<name><surname>Wellish</surname><given-names>M.C.</given-names></name>
<name><surname>Dueland</surname><given-names>A.N.</given-names></name>
<name><surname>Cohrs</surname><given-names>R.J.</given-names></name>
<name><surname>Gilden</surname><given-names>D.H.</given-names></name>
</person-group><article-title>Localization of herpes simplex virus and varicella zoster virus DNA in human ganglia</article-title><source>Ann. Neurol.</source><year>1992</year><volume>31</volume><fpage>444</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1002/ana.410310417</pub-id><pub-id pub-id-type="pmid">1316733</pub-id>
</element-citation></ref><ref id="B41-viruses-16-01909"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Crucian</surname><given-names>B.E.</given-names></name>
<name><surname>Chouk&#x000e8;r</surname><given-names>A.</given-names></name>
<name><surname>Simpson</surname><given-names>R.J.</given-names></name>
<name><surname>Mehta</surname><given-names>S.</given-names></name>
<name><surname>Marshall</surname><given-names>G.</given-names></name>
<name><surname>Smith</surname><given-names>S.M.</given-names></name>
<name><surname>Zwart</surname><given-names>S.R.</given-names></name>
<name><surname>Heer</surname><given-names>M.</given-names></name>
<name><surname>Ponomarev</surname><given-names>S.</given-names></name>
<name><surname>Whitmire</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Immune System Dysregulation During Spaceflight: Potential Countermeasures for Deep Space Exploration Missions</article-title><source>Front. Immunol.</source><year>2018</year><volume>9</volume><elocation-id>1437</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.01437</pub-id><pub-id pub-id-type="pmid">30018614</pub-id>
</element-citation></ref><ref id="B42-viruses-16-01909"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gupta</surname><given-names>K.</given-names></name>
<name><surname>Mahajan</surname><given-names>R.</given-names></name>
</person-group><article-title>Applications and Diagnostic Potential of Dried Blood Spots</article-title><source>Int. J. Appl. Basic Med. Res.</source><year>2018</year><volume>8</volume><fpage>1</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.4103/ijabmr.IJABMR_7_18</pub-id><pub-id pub-id-type="pmid">29552526</pub-id>
</element-citation></ref><ref id="B43-viruses-16-01909"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mehta</surname><given-names>S.K.</given-names></name>
<name><surname>Tyring</surname><given-names>S.K.</given-names></name>
<name><surname>Gilden</surname><given-names>D.H.</given-names></name>
<name><surname>Cohrs</surname><given-names>R.J.</given-names></name>
<name><surname>Leal</surname><given-names>M.J.</given-names></name>
<name><surname>Castro</surname><given-names>V.A.</given-names></name>
<name><surname>Feiveson</surname><given-names>A.H.</given-names></name>
<name><surname>Ott</surname><given-names>C.M.</given-names></name>
<name><surname>Pierson</surname><given-names>D.L.</given-names></name>
</person-group><article-title>Varicella-zoster virus in the saliva of patients with herpes zoster</article-title><source>J. Infect. Dis.</source><year>2008</year><volume>197</volume><fpage>654</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1086/527420</pub-id><pub-id pub-id-type="pmid">18260763</pub-id>
</element-citation></ref><ref id="B44-viruses-16-01909"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hato</surname><given-names>N.</given-names></name>
<name><surname>Kisaki</surname><given-names>H.</given-names></name>
<name><surname>Honda</surname><given-names>N.</given-names></name>
<name><surname>Gyo</surname><given-names>K.</given-names></name>
<name><surname>Murakami</surname><given-names>S.</given-names></name>
<name><surname>Yanagihara</surname><given-names>N.</given-names></name>
</person-group><article-title>Ramsay Hunt syndrome in children</article-title><source>Ann. Neurol.</source><year>2000</year><volume>48</volume><fpage>254</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1002/1531-8249(200008)48:2&#x0003c;254::AID-ANA17&#x0003e;3.0.CO;2-V</pub-id><pub-id pub-id-type="pmid">10939578</pub-id>
</element-citation></ref><ref id="B45-viruses-16-01909"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mehta</surname><given-names>S.K.</given-names></name>
<name><surname>Gilden</surname><given-names>D.</given-names></name>
<name><surname>Crucian</surname><given-names>B.E.</given-names></name>
<name><surname>Sams</surname><given-names>C.F.</given-names></name>
<name><surname>Cohrs</surname><given-names>R.J.</given-names></name>
<name><surname>Pierson</surname><given-names>D.L.</given-names></name>
</person-group><article-title>A Case Report: PCR-Assisted Diagnosis of Varicella in an Adult</article-title><source>Open J. Med. Microbiol.</source><year>2012</year><volume>2</volume><elocation-id>23019</elocation-id><pub-id pub-id-type="doi">10.4236/ojmm.2012.23019</pub-id><pub-id pub-id-type="pmid">24409401</pub-id>
</element-citation></ref><ref id="B46-viruses-16-01909"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nagel</surname><given-names>M.A.</given-names></name>
<name><surname>Choe</surname><given-names>A.</given-names></name>
<name><surname>Cohrs</surname><given-names>R.J.</given-names></name>
<name><surname>Traktinskiy</surname><given-names>I.</given-names></name>
<name><surname>Sorensen</surname><given-names>K.</given-names></name>
<name><surname>Mehta</surname><given-names>S.K.</given-names></name>
<name><surname>Pierson</surname><given-names>D.L.</given-names></name>
<name><surname>Tyring</surname><given-names>S.K.</given-names></name>
<name><surname>Haitz</surname><given-names>K.</given-names></name>
<name><surname>Digiorgio</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>Persistence of varicella zoster virus DNA in saliva after herpes zoster</article-title><source>J. Infect. Dis.</source><year>2011</year><volume>204</volume><fpage>820</fpage><lpage>824</lpage><pub-id pub-id-type="doi">10.1093/infdis/jir425</pub-id><pub-id pub-id-type="pmid">21849278</pub-id>
</element-citation></ref><ref id="B47-viruses-16-01909"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ricklin</surname><given-names>M.E.</given-names></name>
<name><surname>Lorscheider</surname><given-names>J.</given-names></name>
<name><surname>Waschbisch</surname><given-names>A.</given-names></name>
<name><surname>Paroz</surname><given-names>C.</given-names></name>
<name><surname>Mehta</surname><given-names>S.K.</given-names></name>
<name><surname>Pierson</surname><given-names>D.L.</given-names></name>
<name><surname>Kuhle</surname><given-names>J.</given-names></name>
<name><surname>Fischer-Barnicol</surname><given-names>B.</given-names></name>
<name><surname>Sprenger</surname><given-names>T.</given-names></name>
<name><surname>Lindberg</surname><given-names>R.L.</given-names></name>
<etal/>
</person-group><article-title>T-cell response against varicella-zoster virus in fingolimod-treated MS patients</article-title><source>Neurology</source><year>2013</year><volume>81</volume><fpage>174</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e31829a3311</pub-id><pub-id pub-id-type="pmid">23700335</pub-id>
</element-citation></ref><ref id="B48-viruses-16-01909"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gilden</surname><given-names>D.</given-names></name>
<name><surname>Cohrs</surname><given-names>R.J.</given-names></name>
<name><surname>Mahalingam</surname><given-names>R.</given-names></name>
<name><surname>Nagel</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Neurological disease produced by varicella zoster virus reactivation without rash</article-title><source>Curr. Top. Microbiol. Immunol.</source><year>2010</year><volume>342</volume><fpage>243</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1007/82_2009_3</pub-id><pub-id pub-id-type="pmid">20186614</pub-id>
</element-citation></ref><ref id="B49-viruses-16-01909"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pollak</surname><given-names>L.</given-names></name>
<name><surname>Mehta</surname><given-names>S.K.</given-names></name>
<name><surname>Pierson</surname><given-names>D.L.</given-names></name>
<name><surname>Sacagiu</surname><given-names>T.</given-names></name>
<name><surname>Avneri Kalmanovich</surname><given-names>S.</given-names></name>
<name><surname>Cohrs</surname><given-names>R.J.</given-names></name>
</person-group><article-title>Varicella-zoster DNA in saliva of patients with meningoencephalitis: A preliminary study</article-title><source>Acta Neurol. Scand.</source><year>2015</year><volume>131</volume><fpage>417</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1111/ane.12335</pub-id><pub-id pub-id-type="pmid">25314141</pub-id>
</element-citation></ref><ref id="B50-viruses-16-01909"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Christeff</surname><given-names>N.</given-names></name>
<name><surname>Gherbi</surname><given-names>N.</given-names></name>
<name><surname>Mammes</surname><given-names>O.</given-names></name>
<name><surname>Dalle</surname><given-names>M.T.</given-names></name>
<name><surname>Gharakhanian</surname><given-names>S.</given-names></name>
<name><surname>Lortholary</surname><given-names>O.</given-names></name>
<name><surname>Melchior</surname><given-names>J.C.</given-names></name>
<name><surname>Nunez</surname><given-names>E.A.</given-names></name>
</person-group><article-title>Serum cortisol and DHEA concentrations during HIV infection</article-title><source>Psychoneuroendocrinology</source><year>1997</year><volume>22</volume><issue>(Suppl. 1)</issue><fpage>S11</fpage><lpage>S18</lpage><pub-id pub-id-type="doi">10.1016/S0306-4530(97)00015-2</pub-id><pub-id pub-id-type="pmid">9264142</pub-id>
</element-citation></ref><ref id="B51-viruses-16-01909"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Crucian</surname><given-names>B.E.</given-names></name>
<name><surname>Zwart</surname><given-names>S.R.</given-names></name>
<name><surname>Mehta</surname><given-names>S.</given-names></name>
<name><surname>Uchakin</surname><given-names>P.</given-names></name>
<name><surname>Quiriarte</surname><given-names>H.D.</given-names></name>
<name><surname>Pierson</surname><given-names>D.</given-names></name>
<name><surname>Sams</surname><given-names>C.F.</given-names></name>
<name><surname>Smith</surname><given-names>S.M.</given-names></name>
</person-group><article-title>Plasma cytokine concentrations indicate that in vivo hormonal regulation of immunity is altered during long-duration spaceflight</article-title><source>J. Interferon Cytokine Res.</source><year>2014</year><volume>34</volume><fpage>778</fpage><lpage>786</lpage><pub-id pub-id-type="doi">10.1089/jir.2013.0129</pub-id><pub-id pub-id-type="pmid">24702175</pub-id>
</element-citation></ref><ref id="B52-viruses-16-01909"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Williamson</surname><given-names>S.</given-names></name>
<name><surname>Munro</surname><given-names>C.</given-names></name>
<name><surname>Pickler</surname><given-names>R.</given-names></name>
<name><surname>Grap</surname><given-names>M.J.</given-names></name>
<name><surname>Elswick</surname><given-names>R.K.</given-names><suffix>Jr.</suffix></name>
</person-group><article-title>Comparison of biomarkers in blood and saliva in healthy adults</article-title><source>Nurs. Res. Pract.</source><year>2012</year><volume>2012</volume><fpage>246178</fpage><pub-id pub-id-type="doi">10.1155/2012/246178</pub-id><pub-id pub-id-type="pmid">22619709</pub-id>
</element-citation></ref><ref id="B53-viruses-16-01909"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Faustini</surname><given-names>S.E.</given-names></name>
<name><surname>Jossi</surname><given-names>S.E.</given-names></name>
<name><surname>Perez-Toledo</surname><given-names>M.</given-names></name>
<name><surname>Shields</surname><given-names>A.M.</given-names></name>
<name><surname>Allen</surname><given-names>J.D.</given-names></name>
<name><surname>Watanabe</surname><given-names>Y.</given-names></name>
<name><surname>Newby</surname><given-names>M.L.</given-names></name>
<name><surname>Cook</surname><given-names>A.</given-names></name>
<name><surname>Willcox</surname><given-names>C.R.</given-names></name>
<name><surname>Salim</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva</article-title><source>Immunology</source><year>2021</year><volume>164</volume><fpage>135</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1111/imm.13349</pub-id><pub-id pub-id-type="pmid">33932228</pub-id>
</element-citation></ref><ref id="B54-viruses-16-01909"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Obradovic</surname><given-names>M.</given-names></name>
<name><surname>Sudar-Milovanovic</surname><given-names>E.</given-names></name>
<name><surname>Soskic</surname><given-names>S.</given-names></name>
<name><surname>Essack</surname><given-names>M.</given-names></name>
<name><surname>Arya</surname><given-names>S.</given-names></name>
<name><surname>Stewart</surname><given-names>A.J.</given-names></name>
<name><surname>Gojobori</surname><given-names>T.</given-names></name>
<name><surname>Isenovic</surname><given-names>E.R.</given-names></name>
</person-group><article-title>Leptin and Obesity: Role and Clinical Implication</article-title><source>Front. Endocrinol.</source><year>2021</year><volume>12</volume><elocation-id>585887</elocation-id><pub-id pub-id-type="doi">10.3389/fendo.2021.585887</pub-id><pub-id pub-id-type="pmid">34084149</pub-id>
</element-citation></ref><ref id="B55-viruses-16-01909"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pradhan</surname><given-names>G.</given-names></name>
<name><surname>Samson</surname><given-names>S.L.</given-names></name>
<name><surname>Sun</surname><given-names>Y.</given-names></name>
</person-group><article-title>Ghrelin: Much more than a hunger hormone</article-title><source>Curr. Opin. Clin. Nutr. Metab. Care</source><year>2013</year><volume>16</volume><fpage>619</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1097/MCO.0b013e328365b9be</pub-id><pub-id pub-id-type="pmid">24100676</pub-id>
</element-citation></ref><ref id="B56-viruses-16-01909"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dargiewicz</surname><given-names>E.</given-names></name>
<name><surname>Wola&#x00144;ska</surname><given-names>M.</given-names></name>
<name><surname>Sobolewski</surname><given-names>K.</given-names></name>
</person-group><article-title>High Molecular Complexes of Insulin-Like Growth Factor-I in Human Saliva</article-title><source>Int. J. Pept. Res. Ther.</source><year>2014</year><volume>20</volume><fpage>391</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1007/s10989-014-9408-x</pub-id></element-citation></ref><ref id="B57-viruses-16-01909"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sitko</surname><given-names>K.</given-names></name>
<name><surname>Mantej</surname><given-names>J.</given-names></name>
<name><surname>Bednarek</surname><given-names>M.</given-names></name>
<name><surname>Tukaj</surname><given-names>S.</given-names></name>
</person-group><article-title>Detection of autoantibodies to heat shock protein 70 in the saliva and urine of normal individuals</article-title><source>Front. Immunol.</source><year>2024</year><volume>15</volume><elocation-id>1454018</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2024.1454018</pub-id><pub-id pub-id-type="pmid">39136018</pub-id>
</element-citation></ref><ref id="B58-viruses-16-01909"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Khan</surname><given-names>E.S.</given-names></name>
<name><surname>D&#x000e4;inghaus</surname><given-names>T.</given-names></name>
</person-group><article-title>HSP47 in human diseases: Navigating pathophysiology, diagnosis and therapy</article-title><source>Clin. Transl. Med.</source><year>2024</year><volume>14</volume><fpage>e1755</fpage><pub-id pub-id-type="doi">10.1002/ctm2.1755</pub-id><pub-id pub-id-type="pmid">39135385</pub-id>
</element-citation></ref><ref id="B59-viruses-16-01909"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mehta</surname><given-names>S.K.</given-names></name>
<name><surname>Krieger</surname><given-names>S.S.</given-names></name>
<name><surname>Krieger</surname><given-names>S.S.</given-names></name>
<name><surname>Nelman-Gonzalez</surname><given-names>M.</given-names></name>
<name><surname>Nelman-Gonzalez</surname><given-names>M.</given-names></name>
<name><surname>Locke</surname><given-names>J.P.</given-names></name>
<name><surname>Locke</surname><given-names>J.P.</given-names></name>
<name><surname>Nagel</surname><given-names>M.A.</given-names></name>
<name><surname>Nagel</surname><given-names>M.A.</given-names></name>
<name><surname>Young</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Antiviral treatment with valacyclovir reduces virus shedding in saliva of Antarctic expeditioners</article-title><source>Front. Virol.</source><year>2023</year><volume>3</volume><elocation-id>1157659</elocation-id><pub-id pub-id-type="doi">10.3389/fviro.2023.1157659</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="viruses-16-01909-f001"><label>Figure 1</label><caption><p>Saliva Procurement and Integrated Testing (SPIT) booklet.</p></caption><graphic xlink:href="viruses-16-01909-g001" position="float"/></fig><fig position="float" id="viruses-16-01909-f002"><label>Figure 2</label><caption><p>Salivary cortisol to DHEA [C]/[D] ratio comparison between pre-, in-, and post-flight timepoints within the International Space Station and the Space Shuttle eras. There is a significant increase in that ratio during flight for both Space Shuttle (N = 17) or ISS (N = 10). This increase may be associated with lower cellular immunity and innate immunity. This could also contribute to potentially greater inflammatory cytokines that would affect bone remodeling and bone growth. (Image taken from [<xref rid="B21-viruses-16-01909" ref-type="bibr">21</xref>] Copyright &#x000a9; 2019 Rooney, Crucian, Pierson, Laudenslager and Mehta.), * <italic toggle="yes">p</italic> &#x0003c; 0.01.</p></caption><graphic xlink:href="viruses-16-01909-g002" position="float"/></fig></floats-group></article>